Medicus Pharma (MDCX) Current Deferred Tax Assets (2025)

Medicus Pharma (MDCX) posted Current Deferred Tax Assets of $99305.0 for Q4 2025.

Medicus Pharma (MDCX) Current Deferred Tax Assets (2025) Analysis & Trends

Medicus Pharma (MDCX) has reported Current Deferred Tax Assets for 1 consecutive years, with $99305.0 the latest figure, recorded in Q4 2025.

Current Deferred Tax Assets for Q4 2025 came in at $99305.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $99305.0 (changed N/A YoY), and the FY2025 annual result was $99305.0, changed N/A from the prior year.
Current Deferred Tax Assets was $99305.0 for Q4 2025 at Medicus Pharma.
Over five years, Current Deferred Tax Assets peaked at $99305.0 in Q4 2025 and troughed at $99305.0 in Q4 2025.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Medicus Pharma	6.91 Mn	-1.69 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2025	99,305.00
Dec 31, 2025	99,305.00